| Prev Close | 136.17 |
| Day Low/High | 127.70 / 134.39 |
| 52 Wk Low/High | 121.00 / 148.99 |
| Avg Volume | 7.41M |
Johnson & Johnson (JNJ)
127.70
NYSE : Health Technology
| Exchange | NYSE |
| Shares Outstanding | 2.64B |
| Market Cap | 359.38B |
| EPS | 5.70 |
| P/E Ratio | 22.58 |
| Div & Yield | 3.80 (2.79%) |
Cramer: This Market's Like a Seafood Restaurant, Always a Catch of the Day
Today that catch was McDonald's, tomorrow it will probably be something different.
My Takeaways and Observations
"While options can give market participants the protection they are intended to provide, they can also increase the degree of a counter move, once it gets going, as those who wrote the protection scramble to unwind their own exposure." -- Kass Diary...
Cramer: These Research Upgrades Are Actually Having an Impact
Colgate, First Data and Snap, among other stocks, could rise on these analyst actions, and here's why.
Johnson & Johnson Shares May Need a Band-Aid Before They Can Rally
I continue to have my doubts about JNJ rallying to new highs.
Is Johnson & Johnson Sitting Out the Rally?
When a stock isn't doing anything while the market is up, you have to ask questions.
Cramer: Sellers May Be Ready to Give You Some Bargains
The third day of a trading period is typically the day we see sellers, after two up days.
Here's When to Go Long Johnson & Johnson
We remain positive on JNJ.
Positive Signs in Drug Distribution
Blockbuster drugs still need companies to deliver them.
Cramer: 5 Stocks That Turned Negatives Into Positives
This is the kind of action you get when you have a real bull market.
Cramer: Is There a Human Element to This Rally?
It could be all machine-to-machine and not much more than that.
The Best Companies for Women
Working Mother and the National Association of Female Executives surveyed companies and found the best ones that do right by women. Find out who you should be working for.
Cramer: Goldman's Downgrade Of J&J Is 'Questionable'
Johnson & Johnson had a very good acquisition
Johnson & Johnson Is Getting Ready for Another Upside Breakout
A cover shorts signal was triggered, and an outright go long signal could follow soon.
Cramer: Got the Apple-FANG Blues? Look for a Rotation
There's one going on now.
Johnson & Johnson, 3M and 8 Other Winners From the Ridiculously Weaker Dollar
U.S. companies that have significant sales in Europe are about to reap the benefits of a weak greenback.
Cramer: There Should Be More Takeovers Where These Came From
Buying's good for the acquirers, which should give other companies ideas.
Cramer: Ready for the New Normal? Here It Is
Problem areas such as the dollar, oil and retail move to the foreground.
How EY's Kerrie MacPherson Uses Decades of Experience to Help a New Generation of Women Win
EY's Kerrie MacPherson Wants To Pave the Way for future female entrepreneurs.
How JNJ's Chief Medical Officer Fell In Love With Science -- In a Bakery
JNJ's Chief Medical Officer fell in love with science after spending so much time in her family's bakery
My Takeaways and Observations
"I wanted a perfect ending. Now I've learned, the hard way, that some poems don't rhyme, and some stories don't have a clear beginning, middle, and end. Life is about not knowing, having to change, taking the moment and making the best of it, withou...
President Trump Outlines Plans for Fighting in Afghanistan
President Donald Trump said troop levels will be ramped up but no numbers were given.
Cramer: How Picking Stocks Is Like Fantasy Football
Hear me out: The same lessons and disciplines are useful in both.
Don't Get Out of Joint
Demand for artificial joints is growing, and Zimmer Biomet is a good way to play the demographic trend.
CEOs Dump Donald Trump
CEOs exit President's Council after Charlottesville response
Chart Signals End to Dollar Trend
The dollar index is now in an area of strong support.
My Takeaways and Observations (Early Edition)
The story's in the past with nothin' to recall, I've got my life to live and I don't need you at all. The roller-coaster ride we took is nearly at an end, I bought my ticket with my tears, that's all I'm gonna spend. -- The Cyrkle, Red Rubber Ball M...
Here's What Up (and Down)
After 90 minutes of trading here are some market features: * Bonds are getting schmeissed. The 10-year U.S. note yield is close to 2.32% and the long bond is knocking on the door of 3.00%. A possible equity market headwind. * Retail still has a ni...
Biotech Sees Sharp Reversal
Biotech, as represented by iShares Nasdaq Biotechnology Index Fund , universally beloved by technicians and "talking heads" has just suffered an abrupt intraday turnaround. There may be a lesson here -- that charts often tell us where stocks have be...
My Takeaways and Observations (Early Afternoon Edition)
"Keep the juices flowin' by janglin' round gently as you move." -- Jonathan Heller, Catch The Wisdom As of 2PM a most quiet and uneventful day. (Famous Last Words!) "Takeaways" is out early because I have a handful of earnings reports I wanted t...
